- Home
- EBS vs OPY Comparison
EBS vs OPY Comparison
Compare EBS & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- OPY
- Stock Information
- Founded
- EBS 1998
- OPY 1881
- Country
- EBS United States
- OPY United States
- Employees
- EBS 1600
- OPY N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- OPY Investment Bankers/Brokers/Service
- Sector
- EBS Health Care
- OPY Finance
- Exchange
- EBS Nasdaq
- OPY Nasdaq
- Market Cap
- EBS 417.8M
- OPY 675.3M
- IPO Year
- EBS 2006
- OPY N/A
- Fundamental
- Price
- EBS $7.71
- OPY $62.61
- Analyst Decision
- EBS Strong Buy
- OPY
- Analyst Count
- EBS 3
- OPY 0
- Target Price
- EBS $14.33
- OPY N/A
- AVG Volume (30 Days)
- EBS 959.5K
- OPY 19.8K
- Earning Date
- EBS 03-03-2025
- OPY 01-31-2025
- Dividend Yield
- EBS N/A
- OPY 1.13%
- EPS Growth
- EBS N/A
- OPY 145.95
- EPS
- EBS N/A
- OPY 6.37
- Revenue
- EBS $1,125,500,000.00
- OPY $1,344,505,000.00
- Revenue This Year
- EBS $6.26
- OPY N/A
- Revenue Next Year
- EBS $2.42
- OPY N/A
- P/E Ratio
- EBS N/A
- OPY $10.16
- Revenue Growth
- EBS 2.05
- OPY 13.93
- 52 Week Low
- EBS $1.82
- OPY $36.93
- 52 Week High
- EBS $15.10
- OPY $73.12
- Technical
- Relative Strength Index (RSI)
- EBS 28.48
- OPY 37.44
- Support Level
- EBS $7.57
- OPY $62.35
- Resistance Level
- EBS $9.96
- OPY $66.38
- Average True Range (ATR)
- EBS 0.59
- OPY 1.74
- MACD
- EBS -0.35
- OPY -0.60
- Stochastic Oscillator
- EBS 4.07
- OPY 4.06
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has three segments: private client, asset management, and capital markets. The Private Client segment, commissions and a proportionate amount of fee income earned on assets under management ("AUM"), net interest earnings on client margin loans and cash balances, fees from money market funds, and custodian fees. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.